Skip to main content
Fig. 3 | Harm Reduction Journal

Fig. 3

From: The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario

Fig. 3

Proportion of patients retained in treatment for one year, by frequency of BZD use, comparing North vs. South. The pattern of decreased retention with increased proportion of BZD-positive urine samples is not seen in the Southern population, as it is in the Northern population. However, Southern patients with a high proportion of BZD-positive urine samples (≥75%) experienced decreased retention rates

Back to article page